The Valley Desk

NCT01100502 · Interventional trial

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

Overall registry status Completed

Phase 3

Conditions Disease, Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov